Jefferies Financial Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-600
Closed -$60.9K 1884
2025
Q4
$60.9K Buy
+600
New +$48.2K ﹤0.01% 1748
2025
Q1
Sell
-24,000
Closed -$1.35M 1732
2024
Q4
$1.35M Buy
+24,000
New +$1.49M 0.01% 793
2024
Q2
Sell
-17,500
Closed -$1.21M 1539
2024
Q1
$1.21M Sell
17,500
-214,700
-92% -$13.6M 0.01% 752
2023
Q4
$17.2M Buy
232,200
+105,700
+84% +$6.93M 0.11% 125
2023
Q3
$8.63M Buy
126,500
+21,800
+21% +$1.85M 0.08% 196
2023
Q2
$9.83M Buy
104,700
+45,900
+78% +$3.58M 0.09% 207
2023
Q1
$3.99M Sell
58,800
-54,800
-48% -$3.52M 0.03% 432
2022
Q4
$5.62M Buy
+113,600
New +$4.64M 0.04% 374

Other funds holding EXAS

Jefferies Financial Group's EXAS Position: Q1 2026 in Review

Jefferies Financial Group sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 57,816 shares — an estimated $5.87M sold.

Jefferies Financial Group first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $6.59M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Jefferies Financial Group reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Jefferies Financial Group sold 57,816 Exact Sciences shares in Q1 2026, an estimated $5.87M.
  • Jefferies Financial Group first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • Jefferies Financial Group's Exact Sciences position peaked at $6.59M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Jefferies Financial Group's 13F filing for Q1 2026, filed 8 May 2026.